Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
Dapansutrile (10 trials)
pembrolizumab (keytruda) (1 trial)
Heart Failure (Phase 1)
Heart Failure, Systolic (Phase 1)
Osteoarthritis (Phase 2)
Osteoarthritis, Knee (Phase 2)
Schnitzler Syndrome (Phase 2)
Syndrome (Phase 2)
Trials (10 total)
Trial APIs (2 total)